Clinical trials: Pancancer
Pancancer
Prospective Pathology Foundation Models
Histopathology remains the gold standard for disease diagnosis, yet faces challenges including pathologist shortages and diagnostic model limitations.
- Trial name
- NCT07157618
- Where
- 2 sites in China
- Volunteers
- 2,000 people
- Sponsor
- Nanfang Hospital, Southern Medical University
Pancancer
Retrospective Pathology Foundation Models
By integrating retrospective multimodal data such as pathology and imaging, AI technologies offer novel solutions for disease classification, tumor grading, histological and molecular subtyping, selection of chemotherapy…
- Trial name
- NCT07239297
- Where
- 2 sites in China
- Volunteers
- 2,000 people
- Sponsor
- Nanfang Hospital, Southern Medical University
Hepatocellular Carcinoma
An Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC
This study is aimed to establish an organoid-on-chips technological system based on biopsy samples and evaluate its efficacy in predicting the response to mFOLFOX6 infusion in patients with hepatocellular carcinoma (HCC).
- Trial name
- NCT05932836
- Testing
- No interventions.
- Where
- China
- Volunteers
- 226 people
- Sponsor
- Xiangya Hospital of Central South University
Pancancer
Prospective Real-World Study of Multimodal AI
This project proposes to collect prospective multimodal data-such as pathology, imaging, and clinical information-and to perform integrative analyses.
- Trial name
- NCT07269236
- Where
- 2 sites in China
- Volunteers
- 2,000 people
- Sponsor
- Nanfang Hospital, Southern Medical University